Trevi Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
NEA MANAGEMENT COMPANY, LLC | 05/14/2025 | 11.37 M | $71.52 M | 0.00% | 9.67% |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 05/15/2025 | 10.26 M | $64.53 M | -3.80% | 8.72% |
BLACKROCK, INC. | 05/02/2025 | 5.31 M | $33.42 M | 35.23% | 4.52% |
RUBRIC CAPITAL MANAGEMENT LP | 05/14/2025 | 4.54 M | $28.55 M | 7.93% | 3.86% |
VANGUARD GROUP INC | 05/09/2025 | 3.84 M | $24.14 M | 9.37% | 3.26% |
VIVO CAPITAL, LLC | 05/12/2025 | 3.49 M | $21.94 M | 0.00% | 2.97% |
BIOIMPACT CAPITAL LLC | 05/15/2025 | 3.43 M | $21.56 M | 10.77% | 2.92% |
OCTAGON CAPITAL ADVISORS LP | 05/16/2025 | 3.32 M | $20.90 M | 100.00% | 2.82% |
VIKING GLOBAL INVESTORS LP | 05/15/2025 | 3.23 M | $20.30 M | -26.64% | 2.74% |
ARMISTICE CAPITAL, LLC | 05/15/2025 | 2.99 M | $18.79 M | 100.00% | 2.54% |
SIREN, L.L.C. | 05/23/2025 | 2.86 M | $18.01 M | -1.45% | 2.44% |
MARSHALL WACE, LLP | 05/15/2025 | 2.55 M | $16.07 M | 5,850.98% | 2.17% |
POINT72 ASSET MANAGEMENT, L.P. | 05/15/2025 | 2.37 M | $14.89 M | -42.94% | 2.01% |
05/19/2025 | 2.14 M | $13.49 M | 7.19% | 1.82% | |
WOODLINE PARTNERS LP | 05/15/2025 | 2.06 M | $12.94 M | -35.95% | 1.75% |
BALYASNY ASSET MANAGEMENT L.P. | 05/15/2025 | 1.76 M | $11.06 M | 100.00% | 1.50% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 1.61 M | $10.16 M | 24.29% | 1.37% |
STATE STREET CORP | 05/15/2025 | 1.42 M | $8.96 M | 21.68% | 1.21% |
MAI CAPITAL MANAGEMENT | 05/15/2025 | 1.39 M | $8.71 M | 2.08% | 1.18% |
AFFINITY ASSET ADVISORS, LLC | 05/14/2025 | 1.25 M | $7.86 M | 100.00% | 1.06% |
CAPTION MANAGEMENT, LLC | 05/15/2025 | 1.12 M | $7.07 M | 100.00% | 0.96% |
ORBIMED ADVISORS LLC | 05/15/2025 | 1.12 M | $7.04 M | 100.00% | 0.95% |
INVESCO LTD. | 05/12/2025 | 852.99 K | $5.37 M | 3,511.13% | 0.73% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 823.25 K | $5.18 M | 356.30% | 0.70% |
OPALEYE MANAGEMENT INC. | 05/15/2025 | 795.00 K | $5.00 M | -65.70% | 0.68% |
ACUTA CAPITAL PARTNERS, LLC | 05/15/2025 | 785.96 K | $4.94 M | 1.81% | 0.67% |
ALLY BRIDGE GROUP (NY) LLC | 05/15/2025 | 686.22 K | $4.32 M | -12.19% | 0.58% |
VR ADVISER, LLC | 05/15/2025 | 615.51 K | $3.87 M | -51.40% | 0.52% |
ROSALIND ADVISORS, INC. | 05/14/2025 | 612.90 K | $3.86 M | -42.32% | 0.52% |
IKARIAN CAPITAL, LLC | 05/15/2025 | 575.00 K | $3.62 M | 76.92% | 0.49% |
NORTHERN TRUST CORP | 05/13/2025 | 566.20 K | $3.56 M | 17.27% | 0.48% |
EAM INVESTORS, LLC | 05/13/2025 | 550.92 K | $3.47 M | 100.00% | 0.47% |
SILVERARC CAPITAL MANAGEMENT, LLC | 05/14/2025 | 530.00 K | $3.33 M | -27.82% | 0.45% |
RAYMOND JAMES FINANCIAL INC | 05/13/2025 | 509.38 K | $3.20 M | 4,144.83% | 0.43% |
MORGAN STANLEY | 05/15/2025 | 494.57 K | $3.11 M | 159.11% | 0.42% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 440.00 K | $2.77 M | -82.40% | 0.37% |
LOGOS GLOBAL MANAGEMENT LP | 05/15/2025 | 424.72 K | $2.67 B | -66.02% | 0.36% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 05/15/2025 | 340.16 K | $2.14 M | 100.00% | 0.29% |
PANAGORA ASSET MANAGEMENT INC | 05/15/2025 | 339.90 K | $2.14 M | 182.54% | 0.29% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 281.10 K | $1.77 M | 592.23% | 0.24% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 275.70 K | $1.73 M | 109.66% | 0.23% |
05/12/2025 | 273.62 K | $1.72 M | 100.00% | 0.23% | |
GOLDMAN SACHS GROUP INC | 05/16/2025 | 211.87 K | $1.33 M | -10.28% | 0.18% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 207.52 K | $1.31 M | 19.91% | 0.18% |
CUBIST SYSTEMATIC STRATEGIES, LLC | 05/15/2025 | 206.96 K | $1.30 M | 131.74% | 0.18% |
J. GOLDMAN & CO LP | 05/15/2025 | 201.11 K | $1.26 M | -62.59% | 0.17% |
05/15/2025 | 180.00 K | $1.13 M | 100.00% | 0.15% | |
TEJARA CAPITAL LTD | 05/13/2025 | 179.52 K | $1.13 M | 16.77% | 0.15% |
STATE OF WISCONSIN INVESTMENT BOARD | 05/15/2025 | 175.15 K | $1.10 M | 171.54% | 0.15% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 166.08 K | $1.04 M | 18.44% | 0.14% |
Trevi Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 148 institutional investors and hedge funds held shares of Trevi Therapeutics, Inc.. The most heavily invested institutionals were:
NEA Management Company, LLC: 11.37 M
Frazier Life Sciences Management, L.P.: 10.26 M
BlackRock, Inc.: 5.31 M
Rubric Capital Management LP: 4.54 M
VANGUARD GROUP INC: 3.84 M
Vivo Capital, LLC: 3.49 M
74.93% of Trevi Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 93.59 M shares in the last 24 months. This purchase volume represents approximately $637.37 M in transactions.